Julio Garcia Aguilar
Overview
Explore the profile of Julio Garcia Aguilar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosen R, Quezada-Diaz F, Gonen M, Karagkounis G, Widmar M, Wei I, et al.
J Clin Med
. 2024 Apr;
13(8).
PMID: 38673429
Abdominoperineal resection (APR) has been advocated for persistent or recurrent disease after failure of chemoradiation (CRT) for anal squamous cell cancer (SCC). Treatment with salvage APR can potentially achieve a...
2.
Feferman Y, Rosen R, Gebran S, Yuval J, Kerioui M, Gonen M, et al.
Dis Colon Rectum
. 2023 Dec;
67(4):496-504.
PMID: 38127627
Background: Anal adenocarcinoma bears a treatment strategy unique to other anal cancers. Objective: This study aimed to describe oncologic outcomes of total neoadjuvant therapy followed by watch-and-wait approach for anal...
3.
Langenfeld S, Davis B, Vogel J, Davids J, Temple L, Cologne K, et al.
Dis Colon Rectum
. 2023 Aug;
67(1):18-31.
PMID: 37647138
No abstract available.
4.
Klemen N, Court C, Fernandes M, Walch H, Chatila W, Saadat L, et al.
Ann Surg Oncol
. 2022 Aug;
29(13):8373-8382.
PMID: 35930112
Background: Immune checkpoint blockade (ICI) of programmed cell death protein 1 (PD-1) or PD-1 ligand (PD-L1) can induce durable responses in patients who have colorectal cancer (CRC) with a high...
5.
Vos E, Cho J, Schmeltz J, Teri N, Law E, Paisley K, et al.
Ann Surg Oncol
. 2022 Jan;
29(3):1789-1796.
PMID: 34984565
Purpose: For patients who select a specialty hospital for cancer treatment, the wait time until the initial consultation leaves patients anxious and delays treatment. To improve quality of care, we...
6.
Cercek A, Chatila W, Yaeger R, Walch H, Fernandes G, Krishnan A, et al.
J Natl Cancer Inst
. 2021 Aug;
113(12):1683-1692.
PMID: 34405229
Background: The causative factors for the recent increase in early-onset colorectal cancer (EO-CRC) incidence are unknown. We sought to determine if early-onset disease is clinically or genomically distinct from average-onset...
7.
Latham A, Srinivasan P, Kemel Y, Shia J, Bandlamudi C, Mandelker D, et al.
J Clin Oncol
. 2018 Oct;
37(4):286-295.
PMID: 30376427
Purpose: Microsatellite instability (MSI) and/or mismatch repair deficiency (MMR-D) testing has traditionally been performed in patients with colorectal (CRC) and endometrial cancer (EC) to screen for Lynch syndrome (LS)-associated cancer...
8.
Kamboj M, Childers T, Sugalski J, Antonelli D, Bingener-Casey J, Cannon J, et al.
Infect Control Hosp Epidemiol
. 2018 Mar;
39(5):555-562.
PMID: 29553001
BACKGROUNDSurgical site infections (SSIs) following colorectal surgery (CRS) are among the most common healthcare-associated infections (HAIs). Reduction in colorectal SSI rates is an important goal for surgical quality improvement.OBJECTIVETo examine...
9.
Cavnar M, Wang L, Balachandran V, Antonescu C, Tap W, Keohan M, et al.
Ann Surg Oncol
. 2017 Oct;
24(13):3972-3980.
PMID: 29058144
Background: Approximately 5% of gastrointestinal stromal tumors (GISTs) originate in the rectum, and historically, radical resection was commonly performed. Little is known about the outcome for rectal GIST in the...
10.
Ganesh K, Shah R, Vakiani E, Nash G, Skottowe H, Yaeger R, et al.
Cancer
. 2016 Nov;
123(7):1134-1143.
PMID: 27875625
Background: Ovarian metastases from colorectal cancer (OM-CRC) often are unresponsive to chemotherapy and are associated with poor survival. To the authors' knowledge, the clinicopathologic and genomic predictors of OM-CRC are...